Cargando…
Near Normalization of Metabolic and Functional Features of the Central Nervous System in Type 1 Diabetic Patients With End-Stage Renal Disease After Kidney-Pancreas Transplantation
OBJECTIVE: The pathogenesis of brain disorders in type 1 diabetes (T1D) is multifactorial and involves the adverse effects of chronic hyperglycemia and of recurrent hypoglycemia. Kidney-pancreas (KP), but not kidney alone (KD), transplantation is associated with sustained normoglycemia, improvement...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263904/ https://www.ncbi.nlm.nih.gov/pubmed/22190674 http://dx.doi.org/10.2337/dc11-1697 |
_version_ | 1782221947858321408 |
---|---|
author | Fiorina, Paolo Vezzulli, Paolo Bassi, Roberto Gremizzi, Chiara Falautano, Monica D’Addio, Francesca Vergani, Andrea Chabtini, Lola Altamura, Erica Mello, Alessandra Caldara, Rossana Scavini, Marina Magnani, Giuseppe Falini, Andrea Secchi, Antonio |
author_facet | Fiorina, Paolo Vezzulli, Paolo Bassi, Roberto Gremizzi, Chiara Falautano, Monica D’Addio, Francesca Vergani, Andrea Chabtini, Lola Altamura, Erica Mello, Alessandra Caldara, Rossana Scavini, Marina Magnani, Giuseppe Falini, Andrea Secchi, Antonio |
author_sort | Fiorina, Paolo |
collection | PubMed |
description | OBJECTIVE: The pathogenesis of brain disorders in type 1 diabetes (T1D) is multifactorial and involves the adverse effects of chronic hyperglycemia and of recurrent hypoglycemia. Kidney-pancreas (KP), but not kidney alone (KD), transplantation is associated with sustained normoglycemia, improvement in quality of life, and reduction of morbidity/mortality in diabetic patients with end-stage renal disease (ESRD). RESEARCH DESIGN AND METHODS: The aim of our study was to evaluate with magnetic resonance imaging and nuclear magnetic resonance spectroscopy ((1)H MRS) the cerebral morphology and metabolism of 15 ESRD plus T1D patients, 23 patients with ESRD plus T1D after KD (n = 9) and KP (n = 14) transplantation, and 8 age-matched control subjects. RESULTS: Magnetic resonance imaging showed a higher prevalence of cerebrovascular disease in ESRD plus T1D patients (53% [95% CI 36–69]) compared with healthy subjects (25% [3–6], P = 0.04). Brain (1)H MRS showed lower levels of N-acetyl aspartate (NAA)-to-choline ratio in ESRD plus T1D, KD, and KP patients compared with control subjects (control subjects vs. all, P < 0.05) and of NAA-to-creatine ratio in ESRD plus T1D compared with KP and control subjects (ESRD plus T1D vs. control and KP subjects, P ≤ 0.01). The evaluation of the most common scores of psychological and neuropsychological function showed a generally better intellectual profile in control and KP subjects compared with ESRD plus T1D and KD patients. CONCLUSIONS: Diabetes and ESRD are associated with a precocious form of brain impairment, chronic cerebrovascular disease, and cognitive decline. In KP-transplanted patients, most of these features appeared to be near normalized after a 5-year follow-up period of sustained normoglycemia. |
format | Online Article Text |
id | pubmed-3263904 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-32639042013-02-01 Near Normalization of Metabolic and Functional Features of the Central Nervous System in Type 1 Diabetic Patients With End-Stage Renal Disease After Kidney-Pancreas Transplantation Fiorina, Paolo Vezzulli, Paolo Bassi, Roberto Gremizzi, Chiara Falautano, Monica D’Addio, Francesca Vergani, Andrea Chabtini, Lola Altamura, Erica Mello, Alessandra Caldara, Rossana Scavini, Marina Magnani, Giuseppe Falini, Andrea Secchi, Antonio Diabetes Care Original Research OBJECTIVE: The pathogenesis of brain disorders in type 1 diabetes (T1D) is multifactorial and involves the adverse effects of chronic hyperglycemia and of recurrent hypoglycemia. Kidney-pancreas (KP), but not kidney alone (KD), transplantation is associated with sustained normoglycemia, improvement in quality of life, and reduction of morbidity/mortality in diabetic patients with end-stage renal disease (ESRD). RESEARCH DESIGN AND METHODS: The aim of our study was to evaluate with magnetic resonance imaging and nuclear magnetic resonance spectroscopy ((1)H MRS) the cerebral morphology and metabolism of 15 ESRD plus T1D patients, 23 patients with ESRD plus T1D after KD (n = 9) and KP (n = 14) transplantation, and 8 age-matched control subjects. RESULTS: Magnetic resonance imaging showed a higher prevalence of cerebrovascular disease in ESRD plus T1D patients (53% [95% CI 36–69]) compared with healthy subjects (25% [3–6], P = 0.04). Brain (1)H MRS showed lower levels of N-acetyl aspartate (NAA)-to-choline ratio in ESRD plus T1D, KD, and KP patients compared with control subjects (control subjects vs. all, P < 0.05) and of NAA-to-creatine ratio in ESRD plus T1D compared with KP and control subjects (ESRD plus T1D vs. control and KP subjects, P ≤ 0.01). The evaluation of the most common scores of psychological and neuropsychological function showed a generally better intellectual profile in control and KP subjects compared with ESRD plus T1D and KD patients. CONCLUSIONS: Diabetes and ESRD are associated with a precocious form of brain impairment, chronic cerebrovascular disease, and cognitive decline. In KP-transplanted patients, most of these features appeared to be near normalized after a 5-year follow-up period of sustained normoglycemia. American Diabetes Association 2012-02 2012-01-16 /pmc/articles/PMC3263904/ /pubmed/22190674 http://dx.doi.org/10.2337/dc11-1697 Text en © 2012 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Original Research Fiorina, Paolo Vezzulli, Paolo Bassi, Roberto Gremizzi, Chiara Falautano, Monica D’Addio, Francesca Vergani, Andrea Chabtini, Lola Altamura, Erica Mello, Alessandra Caldara, Rossana Scavini, Marina Magnani, Giuseppe Falini, Andrea Secchi, Antonio Near Normalization of Metabolic and Functional Features of the Central Nervous System in Type 1 Diabetic Patients With End-Stage Renal Disease After Kidney-Pancreas Transplantation |
title | Near Normalization of Metabolic and Functional Features of the Central Nervous System in Type 1 Diabetic Patients With End-Stage Renal Disease After Kidney-Pancreas Transplantation |
title_full | Near Normalization of Metabolic and Functional Features of the Central Nervous System in Type 1 Diabetic Patients With End-Stage Renal Disease After Kidney-Pancreas Transplantation |
title_fullStr | Near Normalization of Metabolic and Functional Features of the Central Nervous System in Type 1 Diabetic Patients With End-Stage Renal Disease After Kidney-Pancreas Transplantation |
title_full_unstemmed | Near Normalization of Metabolic and Functional Features of the Central Nervous System in Type 1 Diabetic Patients With End-Stage Renal Disease After Kidney-Pancreas Transplantation |
title_short | Near Normalization of Metabolic and Functional Features of the Central Nervous System in Type 1 Diabetic Patients With End-Stage Renal Disease After Kidney-Pancreas Transplantation |
title_sort | near normalization of metabolic and functional features of the central nervous system in type 1 diabetic patients with end-stage renal disease after kidney-pancreas transplantation |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263904/ https://www.ncbi.nlm.nih.gov/pubmed/22190674 http://dx.doi.org/10.2337/dc11-1697 |
work_keys_str_mv | AT fiorinapaolo nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation AT vezzullipaolo nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation AT bassiroberto nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation AT gremizzichiara nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation AT falautanomonica nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation AT daddiofrancesca nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation AT verganiandrea nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation AT chabtinilola nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation AT altamuraerica nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation AT melloalessandra nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation AT caldararossana nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation AT scavinimarina nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation AT magnanigiuseppe nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation AT faliniandrea nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation AT secchiantonio nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation |